| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), QURE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 540.3K | $10.48M | - | |
| CFO | 226.6K | $2.05M | - | |
| Other | 133.2K | $3.69M | - | |
| Other | 108.9K | $2.95M | - | |
| Other | 50.5K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | O'Keefe Kylie | Chief Customer &Strat Officer | Sell | 15,936 | $27.06 | $431,228.16 | -12.8% | - | - | |
| Jun 11, 2026 | Kaye Jack48 | Director | Sell | 1,993 | $27.06 | $53,930.58 | -7.1% | - | - | |
| Jun 11, 2026 | Jacques Rachelle Suzanne45 | Director | Sell | 1,993 | $27.06 | $53,930.58 | -5.6% | - | - | |
| Jun 11, 2026 | Gut Robert65 | Director | Sale+OE | 10,278 | $26.32 | $270,485.52 | -24.2% | - | - | |
| Jun 11, 2026 | Balachandran Madhavan46 | Director | Sell | 1,993 | $27.06 | $53,930.58 | -4.4% | - | - | |
| Jun 11, 2026 | Meek David D.46 | Director | Sell | 1,993 | $27.06 | $53,930.58 | -4.8% | - | - | |
| Jun 11, 2026 | Springhorn Jeremy P.46 | Director | Sell | 1,993 | $27.06 | $53,930.58 | -4.4% | - | - | |
| Jun 11, 2026 | Post Leonard E | Director | Sell | 1,993 | $27.06 | $53,930.58 | -5.3% | - | - | |
| Jun 3, 2026 | Kaye Jack48 | Director | Sale+OE | 2,645 | $30.01 | $79,376.45 | -11.5% | - | - | |
| May 8, 2026 | Abi-Saab Walid | Chief Medical Officer | Sale+OE | 45,000 | $25.06 | $1,127,500.00 | -21.0% | - | - |